C01EB16 ibuprofen

CARDIOVASCULAR SYSTEM CARDIAC THERAPY OTHER CARDIAC PREPARATIONS Other cardiac preparations

非健保收載 TFDA 在效許可證 8 FDA 已核准

台灣藥品與外觀

台灣食藥署在效西藥許可證 8 張;以下列出 5 個品項。

無外觀照
異布洛芬50
無外觀照
脈閉佳注射液5毫克/毫升
無外觀照
異布洛芬
無外觀照
異布洛芬
無外觀照
異布洛芬70

資料來源:食藥署「西藥許可證」+「藥品 ATC 碼」+「藥品外觀」+「藥品仿單或外盒」開放資料。外觀照與仿單連結指向食藥署原始檔。

適應症

台灣 TFDA 核准適應症

  1. 鎮痛、消炎藥。
  2. 治療胎齡小於34週早產新生兒之血液動力學表現顯著開放性動脈導管。
  3. 消炎鎮痛劑。
  4. 消炎鎮痛藥。
  5. 消炎劑。

美國 FDA 適應症(英文原文對照)

美國 FDA 核准成分 ibuprofen and famotidine (商品名 ADVIL COLD AND SINUS / AMAZON BASIC CARE IBUPROFEN / AMAZON BASIC CARE IBUPROFEN PM / Acetaminophen and Ibuprofen / Advil / Advil Dual Action with Acetaminophen, Travel BASIX) · 仿單更新 2026-04-29

1 INDICATIONS AND USAGE Ibuprofen and famotidine tablet, a combination of the NSAID ibuprofen and the histamine H 2 -receptor antagonist famotidine, is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers, which in the clinical trials was defined as a gastric and/or duodenal ulcer, in patients who are taking ibuprofen for those indications. The clinical trials primarily enrolled patients less than 65 years of age without a prior history of gastrointestinal ulcer. Controlled trials do not extend beyond 6 months [see Clinical Studies (14), Use in Specific Populations (8.5)] . Ibuprofen and famotidine tablet, a combination of a nonsteroidal anti-inflammatory drug (NSAID) ibuprofen and the histamine H 2 -receptor antagonist famotidine, is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers, which in the clinical trials was defined as a gastric and/or duodenal ulcer, in patients who are taking ibuprofen for those indications. The clinical trials primarily enrolled patients less than 65 years of age without a prior history of gastrointestinal ulcer. Controlled trials do not extend beyond 6 months. (1)

資料來源:食藥署西藥許可證適應症(中文)、openFDA US SPL(英文,僅供對照)。

健保給付規定

查無健保特殊給付規定條款;本藥品依一般健保藥品支付規定給付。

實證補充

本藥品尚無實證補充整理(未來新增 Review/指引知識時補列)。


台灣藥品與適應症:食藥署西藥許可證+ATC+外觀+仿單開放資料 · FDA:openFDA US SPL · 健保給付:健保署「全民健康保險藥品給付規定」(更新日 2026-06-09)· 實證補充:人工彙整。 本頁為資訊整理,實際給付與適應症以主管機關公告為準。